Efficacy and Tolerability of Travoprost 0.004/Timolol 0.5 Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

Table 1

Demographics and baseline characteristics (ITT population).

	TTFC; ()	Beta-blocker; ()	Overall; ()
Mean age ± SD (range), years	62.8 ± 12.8 (20–86)	63.8 ± 13.3 (22–86)	63.3 ± 13.0 (20–86)
Gender
Female, (%)	54 (69.2)	52 (71.2)	106 (70.2)
Race, (%)
White	58 (74.4)	52 (71.2)	110 (72.8)
Asian	12 (15.4)	10 (13.7)	22 (14.6)
Others	8 (10.3)	11 (15.1)	19 (12.6)
Underlying eye disease, (%)
OAG	61 (78.2)	58 (79.5)	119 (78.8)
OHT	17 (21.8)	15 (20.5)	32 (21.2)

ITT, intent-to-treat; OAG, open-angle glaucoma; OHT, ocular hypertension; SD, standard deviation; TTFC, travoprost 0.004%/timolol 0.5% fixed-dose combination.